Literature DB >> 21777296

A scoring model of factors associated with Candida glabrata candidemia among critically ill patients.

Gino G Tapia1, Raymund R Razonable, Jeanette E Eckel-Passow, Brian D Lahr, Bekele Afessa, Mark T Keegan, Jelena Catania, Larry M Baddour.   

Abstract

Candida species, including Candida glabrata (CG), are common causes of bloodstream infections among intensive care unit (ICU) patients. Many CG isolates have decreased susceptibility to fluconazole. Constructing a scoring model of factors associated with CG candidemia in ICU patients that can be used if fluconazole susceptibility testing is not readily available. We identified patients with candidemia that were admitted to the ICU of the Mayo Clinic in Rochester, Minnesota from 1998 to 2006. Using patient demographical and clinical data abstracted via chart review, a multivariable logistic regression model was developed to distinguish those with CG candidemia. We identified 246 patients with candidemia including 68 CG cases. Multivariable analysis identified four independent factors associated with CG candidemia: absence of renal failure, less than 7 days in the hospital, abdominal surgery and fluconazole use. The predictive ability of the model, based on the c-statistic, was 0.727. In a large ICU cohort, a scoring model that included four risk factors, which are readily ascertainable at the bedside, was created to distinguish candidemia due to CG from other causes of candidemia. The identification of risk factors associated with CG candidemia could aid physicians in the selection of the optimal initial antifungal therapy.
© 2011 Blackwell Verlag GmbH.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21777296     DOI: 10.1111/j.1439-0507.2011.02069.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  5 in total

1.  Impact of prior inappropriate fluconazole dosing on isolation of fluconazole-nonsusceptible Candida species in hospitalized patients with candidemia.

Authors:  Dhara N Shah; Raymond Yau; Todd M Lasco; Jaye Weston; Miguel Salazar; Hannah R Palmer; Kevin W Garey
Journal:  Antimicrob Agents Chemother       Date:  2012-03-12       Impact factor: 5.191

2.  A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts.

Authors:  Matteo Bassetti; Monia Marchetti; Arunaloke Chakrabarti; Sergio Colizza; Jose Garnacho-Montero; Daniel H Kett; Patricia Munoz; Francesco Cristini; Anastasia Andoniadou; Pierluigi Viale; Giorgio Della Rocca; Emmanuel Roilides; Gabriele Sganga; Thomas J Walsh; Carlo Tascini; Mario Tumbarello; Francesco Menichetti; Elda Righi; Christian Eckmann; Claudio Viscoli; Andrew F Shorr; Olivier Leroy; George Petrikos; Francesco Giuseppe De Rosa
Journal:  Intensive Care Med       Date:  2013-10-09       Impact factor: 17.440

3.  Comments on "Candida glabrata candidemia; an emerging threat in critically ill patients".

Authors:  Armin Ahmed; Afzal Azim; Arvind Kumar Baronia
Journal:  Indian J Crit Care Med       Date:  2015-05

4.  Evaluation of blood culture media for the detection of fungi.

Authors:  U Nawrot; B Kowalska-Krochmal; B Sulik-Tyszka; M Kozak; K Świętek; M Pajączkowska; E Piątkowska; D Rosiak; E Swoboda-Kopeć
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-08-08       Impact factor: 3.267

5.  Prevalence and Antifungal Susceptibility of the Emerging Fungal Species, Candida nivariensis, Isolated in a Teaching Hospital in Poland.

Authors:  Magdalena Sikora; Robert Kuthan; Katarzyna Piskorska-Malolepsza; Marlena Golas-Pradzynska; Dariusz Domański; Ewa Augustynowicz-Kopeć; Ewa Swoboda-Kopec
Journal:  Pol J Microbiol       Date:  2019-09-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.